Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.

Abroad (travel likely)RecruitingPHASE3

Conditions

Hereditary Spastic Paraplegia Type 50

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Texas Southwestern Medical Center, Dallas, Texas, United States

  • Sant Joan de Deu, Barcelona, Spain